Joseph P. Lucia & Associates, LLC Novo Nordisk A S Transaction History

Joseph P. Lucia & Associates, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	BUY	$93.1 - $112.54 $28,861 - $34,887	310 New	310 $34,000
Q4 2021 Feb 04, 2022	SELL	$95.88 - $117.08 $29,722 - $36,294	-310 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$63.89 - $73.8 $19,805 - $22,878	310 New	310 $22,000
Q3 2020 Oct 20, 2020	SELL	$63.69 - $70.22 $19,743 - $21,768	-310 Closed	0 $0
Q1 2020 Apr 22, 2020	BUY	$49.46 - $64.78 $15,332 - $20,081	310 New	310 $19,000

1,955

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $193B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Joseph P. Lucia & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Joseph P. Lucia & Associates, LLC with notifications on news.